Caribou Biosciences (CRBU) FCF Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,329.00 |
| Dec 31, 2025 | 62,793.00 |
| Sep 30, 2025 | -4,107.00 |
| Jun 30, 2025 | 45,569.00 |
| Mar 31, 2025 | 16,043.00 |
| Dec 31, 2024 | -10,263.00 |
| Sep 30, 2024 | -69,420.00 |
| Jun 30, 2024 | 63,738.00 |
| Mar 31, 2024 | -96,196.00 |
| Dec 31, 2023 | -50,005.00 |
| Sep 30, 2023 | 37,619.00 |
| Jun 30, 2023 | 36,592.00 |
| Mar 31, 2023 | -26,251.00 |
| Dec 31, 2022 | 21,401.00 |
| Sep 30, 2022 | -28,300.00 |
| Jun 30, 2022 | 33,513.00 |
| Mar 31, 2022 | 1,223.00 |
| Dec 31, 2021 | -46,288.00 |
| Sep 30, 2021 | 74,933.00 |
| Jun 30, 2021 | -242,843.00 |
| Mar 31, 2021 | 210,286.00 |
| Dec 31, 2020 | -9,685.00 |